Xeris Biopharma Holdings, Inc. ($XERS)
Filing Information
| Accession Number | 0001867096-26-000038 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
72,689
Total Value
$294,358.35
P&L
+151.9% (+$308,344.26)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 3, 2026 | Sale | 15,500 | $5.90 | $91,432.95 | 126,500 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 4, 2026 | Grant/Award | 24,193 | $0.00 | $0.00 | 150,693 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 4, 2026 | Grant/Award | 32,996 | $6.15 | $202,925.40 | 32,996 | Direct | โ | View Details |